Coverage
-
January 14, 2016
Novartis Pharmaceuticals Corp. and Actavis LLC have agreed to settle claims that the generic drug maker's use of a drug ingredient infringed Novartis' patents, according to a court documents filed in New Jersey federal court on Thursday.
2 other articles on this case.
View all »